Product NDC: | 0039-0078 |
Proprietary Name: | Trental |
Non Proprietary Name: | pentoxifylline |
Active Ingredient(s): | 400 mg/1 & nbsp; pentoxifylline |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0039-0078 |
Labeler Name: | Sanofi-Aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018631 |
Marketing Category: | NDA |
Start Marketing Date: | 19840830 |
Package NDC: | 0039-0078-10 |
Package Description: | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0039-0078-10) |
NDC Code | 0039-0078-10 |
Proprietary Name | Trental |
Package Description | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0039-0078-10) |
Product NDC | 0039-0078 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | pentoxifylline |
Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19840830 |
Marketing Category Name | NDA |
Labeler Name | Sanofi-Aventis U.S. LLC |
Substance Name | PENTOXIFYLLINE |
Strength Number | 400 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] |